HIGH-DOSE PANCREATIC-ENZYMES IN CYSTIC-FIBROSIS

被引:33
作者
ROBINSON, PJ [1 ]
SLY, PD [1 ]
机构
[1] ROYAL CHILDRENS HOSP,DEPT THORAC MED,PARKVILLE,VIC 3052,AUSTRALIA
关键词
D O I
10.1136/adc.65.3.311
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.
引用
收藏
页码:311 / 312
页数:2
相关论文
共 3 条
[1]   INTESTINAL DISEASE IN CYSTIC-FIBROSIS [J].
BAXTER, PS ;
DICKSON, JAS ;
VARIEND, S ;
TAYLOR, CJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (12) :1496-1497
[2]   LIVER-DISEASE AND COMMON-BILE-DUCT STENOSIS IN CYSTIC-FIBROSIS [J].
GASKIN, KJ ;
WATERS, DLM ;
HOWMANGILES, R ;
DESILVA, M ;
EARL, JW ;
MARTIN, HCO ;
KAN, AE ;
BROWN, JM ;
DORNEY, SFA .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (06) :340-346
[3]  
VANDEKAMER JH, 1949, J BIOL CHEM, V177, P347